在引起深静脉血栓形成后,减少儿童的抗凝血时间
Benjamin Feijóo1, Roxanne Radi2, Corey Lyon1
1From the University of Colorado Family Medicine Residency, Aurora, CO (BF, RR, CL).
Journal of the American Board of Family Medicine : JABFM
|August 25, 2025
概括
对于患有引起深静脉血栓症 (DVT) 的年轻患者,6周的抗凝治疗与3个月的治疗方案一样有效. 这一发现支持儿童和青少年DVT病例的治疗时间更短.
科学领域:
- 血液学
- 儿童血栓形成
- 血管医学
背景情况:
- 深静脉血栓 (DVT) 是一种严重的血管疾病.
- 儿童和青少年群体的最佳抗凝时间仍在研究中.
- 在年轻人中引起的DVT带来了独特的管理挑战.
研究的目的:
- 为了比较6周和3个月的抗凝药在21岁以下的患者中引起的DVT的疗效和安全性.
- 为了确定较短的抗凝时间的非劣质性.
- 为儿童DVT治疗提供临床指南.
主要方法:
- 未来的研究设计.
- 包括21岁以下的患者,首次出现引起的DVT.
- 随机分为6周或3个月的抗凝药治疗.
- 对复发性静脉血栓塞和出血事件进行监测.
主要成果:
- 在预防复发性DVT方面,六周的抗凝药效果不低于3个月.
- 在两次治疗期间,主要出血事件没有显著差异.
- 该研究达到其主要非劣势终点.
结论:
- 在21岁以下的患者中,为期3个月的抗凝疗疗程是安全有效的替代方案.
- 较短的抗凝时间可能会减少治疗负担和潜在的并发症.
- 这些发现支持基于诱发因素和患者年龄的个性化治疗策略.
相关概念视频
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Anticoagulant Drugs: Low-Molecular-Weight Heparins
893
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
893
Venous Thrombosis IV: Nursing Management
23
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
23
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
34
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
34
Venous Thrombosis I: Introduction
40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40


